Justin Bowers
Stock Analyst at Deutsche Bank
(1.86)
# 3,267
Out of 5,150 analysts
40
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $319.04 | -1.27% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $465.86 | -7.70% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $177.88 | +48.98% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $10.38 | +121.58% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $23.56 | +23.09% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $22.37 | +11.76% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $125.84 | +23.17% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $512.69 | +18.98% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $57.85 | +41.75% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $8.65 | +189.02% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.82 | +345.03% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $110.20 | +172.23% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $204.73 | +34.32% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $248.84 | +0.47% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $179.58 | +61.49% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.25 | +183.08% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $319.04
Upside: -1.27%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $465.86
Upside: -7.70%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $177.88
Upside: +48.98%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $10.38
Upside: +121.58%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $23.56
Upside: +23.09%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $22.37
Upside: +11.76%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $125.84
Upside: +23.17%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $512.69
Upside: +18.98%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $57.85
Upside: +41.75%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $8.65
Upside: +189.02%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.82
Upside: +345.03%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $110.20
Upside: +172.23%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $204.73
Upside: +34.32%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $248.84
Upside: +0.47%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $179.58
Upside: +61.49%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.25
Upside: +183.08%